Top compounds associated with response to PRNT


Feature Type Standardized
Nominal ANOVA
mRNA tandutinib CTRPv2 pan-cancer AAC 0.036 0.3
mRNA CID-5951923 CTRPv2 pan-cancer AAC 0.037 0.3
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.036 0.3
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.034 0.3
mRNA BRD-K88742110 CTRPv2 pan-cancer AAC 0.035 0.3
mRNA HLI 373 CTRPv2 pan-cancer AAC -0.034 0.3
mRNA BRD-K96431673 CTRPv2 pan-cancer AAC -0.071 0.3
mRNA IC-87114 CTRPv2 pan-cancer AAC -0.036 0.3
mRNA BRD-K85133207 CTRPv2 pan-cancer AAC -0.036 0.3
mRNA BRD-K27986637 CTRPv2 pan-cancer AAC 0.071 0.3
Download CSV